Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Fosfomycin.

Falagas ME, Vouloumanou EK, Samonis G, Vardakas KZ.

Clin Microbiol Rev. 2016 Apr;29(2):321-47. doi: 10.1128/CMR.00068-15. Review.

2.

Susceptibility patterns of uropathogens identified in hospitalised children with community-acquired urinary tract infections in Thrace, Greece.

Mantadakis E, Vouloumanou EK, Panopoulou M, Tsouvala E, Tsalkidis A, Chatzimichael A, Falagas ME.

J Glob Antimicrob Resist. 2015 Jun;3(2):85-90. doi: 10.1016/j.jgar.2015.02.006. Epub 2015 Mar 28.

PMID:
27873675
3.

Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis.

Machaira M, Papaevangelou V, Vouloumanou EK, Tansarli GS, Falagas ME.

J Antimicrob Chemother. 2015 Feb;70(2):396-404. doi: 10.1093/jac/dku404. Epub 2014 Oct 31. Review.

PMID:
25362571
4.

Use of real-time polymerase chain reaction for the diagnosis of Pneumocystis pneumonia in immunocompromised patients: a meta-analysis.

Summah H, Zhu YG, Falagas ME, Vouloumanou EK, Qu JM.

Chin Med J (Engl). 2013;126(10):1965-73.

PMID:
23673119
5.

Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance.

Samonis G, Maraki S, Vouloumanou EK, Georgantzi GG, Kofteridis DP, Falagas ME.

Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3191-8. doi: 10.1007/s10096-012-1684-9. Epub 2012 Jul 1.

PMID:
22752194
6.

Deep venous thrombosis in children with musculoskeletal infections: the clinical evidence.

Mantadakis E, Plessa E, Vouloumanou EK, Michailidis L, Chatzimichael A, Falagas ME.

Int J Infect Dis. 2012 Apr;16(4):e236-43. doi: 10.1016/j.ijid.2011.12.012. Epub 2012 Feb 22. Review.

7.

Morbidity of foreign travelers in Attica, Greece: a retrospective study.

Theocharis G, Polyzos KA, Vouloumanou EK, Peppas G, Spiropoulos T, Barbas SG, Falagas ME.

Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2141-6.

PMID:
22298239
8.

Immediate hematological toxicity of linezolid in healthy volunteers with different body weight: a phase I clinical trial.

Cai Y, Chai D, Falagas ME, Vouloumanou EK, Wang R, Guo D, Bai N, Liang B, Liu Y.

J Antibiot (Tokyo). 2012 Apr;65(4):175-8. doi: 10.1038/ja.2011.142. Epub 2012 Jan 25.

PMID:
22274702
9.

Comparison of morbidity of elderly patients in August and November in Attica, Greece: a prospective study.

Theocharis G, Mavros MN, Vouloumanou EK, Peppas G, Barbas SG, Spiropoulos T, Falagas ME.

Int J Clin Pract. 2012 Jan;66(1):84-90. doi: 10.1111/j.1742-1241.2011.02811.x.

PMID:
22171908
10.

Current diagnosis and management of infectious mononucleosis.

Vouloumanou EK, Rafailidis PI, Falagas ME.

Curr Opin Hematol. 2012 Jan;19(1):14-20. doi: 10.1097/MOH.0b013e32834daa08. Review.

PMID:
22123662
11.

Sutures versus staples for the management of surgical wounds: a meta-analysis of randomized controlled trials.

Iavazzo C, Gkegkes ID, Vouloumanou EK, Mamais I, Peppas G, Falagas ME.

Am Surg. 2011 Sep;77(9):1206-21. Review.

PMID:
21944632
12.

Ciprofloxacin in critically ill children.

Sideri G, Kafetzis DA, Vouloumanou EK, Papadatos JH, Papadimitriou M, Falagas ME.

Anaesth Intensive Care. 2011 Jul;39(4):635-9.

13.

Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates.

Samonis G, Maraki S, Karageorgopoulos DE, Vouloumanou EK, Falagas ME.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):695-701. doi: 10.1007/s10096-011-1360-5. Epub 2011 Jul 31.

PMID:
21805292
14.

Liposomal amphotericin B in critically ill paediatric patients.

Sideri G, Falagas ME, Grigoriou M, Vouloumanou EK, Papadatos JH, Lebessi E, Kafetzis DA.

J Clin Pharm Ther. 2012 Jun;37(3):291-5. doi: 10.1111/j.1365-2710.2011.01288.x. Epub 2011 Jul 21.

PMID:
21777406
15.

Comparison of characteristics of outpatients with 2009 H1N1 pandemic and seasonal influenza.

Theocharis G, Vouloumanou EK, Barbas SG, Spiropoulos T, Rafailidis PI, Falagas ME.

Int J Clin Pract. 2011 Aug;65(8):871-8. doi: 10.1111/j.1742-1241.2011.02684.x.

PMID:
21762312
16.

Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza.

Karageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME.

PLoS One. 2011;6(7):e21690. doi: 10.1371/journal.pone.0021690. Epub 2011 Jul 1.

17.

Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence.

Vouloumanou EK, Karageorgopoulos DE, Rafailidis PI, Michalopoulos A, Falagas ME.

Int J Antimicrob Agents. 2011 Sep;38(3):197-216. doi: 10.1016/j.ijantimicag.2011.04.016. Epub 2011 Jul 13. Review.

PMID:
21741802
18.

Acute Tc-99m DMSA scan for identifying dilating vesicoureteral reflux in children: a meta-analysis.

Mantadakis E, Vouloumanou EK, Georgantzi GG, Tsalkidis A, Chatzimichael A, Falagas ME.

Pediatrics. 2011 Jul;128(1):e169-79. doi: 10.1542/peds.2010-3460. Epub 2011 Jun 13.

PMID:
21669900
19.

Knowledge and practices regarding prevention of infections associated with central venous catheters: a survey of intensive care unit medical and nursing staff.

Koutzavekiaris I, Vouloumanou EK, Gourni M, Rafailidis PI, Michalopoulos A, Falagas ME.

Am J Infect Control. 2011 Sep;39(7):542-7. doi: 10.1016/j.ajic.2010.11.003. Epub 2011 Apr 15.

PMID:
21496955
20.

Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis.

Vouloumanou EK, Plessa E, Karageorgopoulos DE, Mantadakis E, Falagas ME.

Intensive Care Med. 2011 May;37(5):747-62. doi: 10.1007/s00134-011-2174-8. Epub 2011 Mar 5. Review.

PMID:
21380522
21.

β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.

Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME.

Clin Infect Dis. 2011 Mar 15;52(6):750-70. doi: 10.1093/cid/ciq206.

PMID:
21367728
22.

Serratia infections in a general hospital: characteristics and outcomes.

Samonis G, Vouloumanou EK, Christofaki M, Dimopoulou D, Maraki S, Triantafyllou E, Kofteridis DP, Falagas ME.

Eur J Clin Microbiol Infect Dis. 2011 May;30(5):653-60. doi: 10.1007/s10096-010-1135-4. Epub 2011 Jan 10.

PMID:
21222011
23.

Evaluation of a direct test for seasonal influenza in outpatients.

Theocharis G, Vouloumanou EK, Rafailidis PI, Spiropoulos T, Barbas SG, Falagas ME.

Eur J Intern Med. 2010 Oct;21(5):434-8. doi: 10.1016/j.ejim.2010.06.013. Epub 2010 Jul 22.

PMID:
20816600
24.

Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis.

Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA.

Pediatr Pulmonol. 2010 Nov;45(11):1135-40. doi: 10.1002/ppul.21302.

PMID:
20658485
25.

Inaccuracies in dosing drugs with teaspoons and tablespoons.

Falagas ME, Vouloumanou EK, Plessa E, Peppas G, Rafailidis PI.

Int J Clin Pract. 2010 Aug;64(9):1185-9. doi: 10.1111/j.1742-1241.2010.02402.x.

PMID:
20653796
26.

Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere.

Falagas ME, Cholevas NV, Kapaskelis AM, Vouloumanou EK, Michalopoulos A, Rafailidis PI.

Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1327-47. doi: 10.1007/s10096-010-1002-3. Epub 2010 Jul 13. Review.

PMID:
20623384
27.

Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials.

Falagas ME, Vouloumanou EK, Togias AG, Karadima M, Kapaskelis AM, Rafailidis PI, Athanasiou S.

J Antimicrob Chemother. 2010 Sep;65(9):1862-77. doi: 10.1093/jac/dkq237. Epub 2010 Jun 29. Review.

PMID:
20587612
28.

Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials.

Falagas ME, Koletsi PK, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Rello J.

J Antimicrob Chemother. 2010 Jul;65(7):1330-46. doi: 10.1093/jac/dkq158. Epub 2010 May 20.

PMID:
20488984
29.

Patients included in randomised controlled trials do not represent those seen in clinical practice: focus on antimicrobial agents.

Falagas ME, Vouloumanou EK, Sgouros K, Athanasiou S, Peppas G, Siempos II.

Int J Antimicrob Agents. 2010 Jul;36(1):1-13. doi: 10.1016/j.ijantimicag.2010.03.020. Epub 2010 May 11. Review.

PMID:
20462742
30.

Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.

Kastoris AC, Rafailidis PI, Vouloumanou EK, Gkegkes ID, Falagas ME.

Eur J Clin Pharmacol. 2010 Apr;66(4):359-68. doi: 10.1007/s00228-010-0794-5. Epub 2010 Feb 26.

PMID:
20186407
31.

Treatment options for 2009 H1N1 influenza: evaluation of the published evidence.

Falagas ME, Vouloumanou EK, Baskouta E, Rafailidis PI, Polyzos K, Rello J.

Int J Antimicrob Agents. 2010 May;35(5):421-30. doi: 10.1016/j.ijantimicag.2010.01.006. Epub 2010 Feb 24. Review.

PMID:
20185273
32.

Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature.

Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G.

Future Microbiol. 2009 Nov;4(9):1103-9. doi: 10.2217/fmb.09.84. Review.

PMID:
19895214
33.

Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies.

Mantadakis E, Plessa E, Vouloumanou EK, Karageorgopoulos DE, Chatzimichael A, Falagas ME.

J Pediatr. 2009 Dec;155(6):875-881.e1. doi: 10.1016/j.jpeds.2009.06.037. Epub 2009 Oct 21.

PMID:
19850301
34.

Seasonality of mortality: the September phenomenon in Mediterranean countries.

Falagas ME, Karageorgopoulos DE, Moraitis LI, Vouloumanou EK, Roussos N, Peppas G, Rafailidis PI.

CMAJ. 2009 Oct 13;181(8):484-6. doi: 10.1503/cmaj.090694. Epub 2009 Sep 21.

35.

Susceptibility of urinary tract bacteria to fosfomycin.

Maraki S, Samonis G, Rafailidis PI, Vouloumanou EK, Mavromanolakis E, Falagas ME.

Antimicrob Agents Chemother. 2009 Oct;53(10):4508-10. doi: 10.1128/AAC.00721-09. Epub 2009 Aug 17.

36.

Economic crises and mortality: a review of the literature.

Falagas ME, Vouloumanou EK, Mavros MN, Karageorgopoulos DE.

Int J Clin Pract. 2009 Aug;63(8):1128-35. doi: 10.1111/j.1742-1241.2009.02124.x. Review.

PMID:
19624782
37.

Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials.

Vouloumanou EK, Karageorgopoulos DE, Kazantzi MS, Kapaskelis AM, Falagas ME.

J Antimicrob Chemother. 2009 Jul;64(1):16-24. doi: 10.1093/jac/dkp166. Epub 2009 May 19. Review.

PMID:
19454521
38.

Community-acquired Stenotrophomonas maltophilia infections: a systematic review.

Falagas ME, Kastoris AC, Vouloumanou EK, Dimopoulos G.

Eur J Clin Microbiol Infect Dis. 2009 Jul;28(7):719-30. doi: 10.1007/s10096-009-0709-5. Epub 2009 Feb 18. Review.

PMID:
19224257
39.

Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials.

Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI.

J Infect. 2009 Feb;58(2):91-102. doi: 10.1016/j.jinf.2008.12.009. Epub 2009 Feb 4. Review.

PMID:
19195714
40.

Probiotics for the prevention of respiratory tract infections: a systematic review.

Vouloumanou EK, Makris GC, Karageorgopoulos DE, Falagas ME.

Int J Antimicrob Agents. 2009 Sep;34(3):197.e1-10. doi: 10.1016/j.ijantimicag.2008.11.005. Epub 2009 Jan 28. Review.

PMID:
19179052
41.

Systemic colistin use in children without cystic fibrosis: a systematic review of the literature.

Falagas ME, Vouloumanou EK, Rafailidis PI.

Int J Antimicrob Agents. 2009 Jun;33(6):503.e1-503.e13. doi: 10.1016/j.ijantimicag.2008.10.021. Epub 2009 Jan 24. Review.

PMID:
19168333
42.

Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.

Falagas ME, Sideri G, Vouloumanou EK, Papadatos JH, Kafetzis DA.

Pediatr Infect Dis J. 2009 Feb;28(2):123-7. doi: 10.1097/INF.0b013e31818a5dbd.

PMID:
19116601
43.

Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials.

Vouloumanou EK, Rafailidis PI, Kazantzi MS, Athanasiou S, Falagas ME.

Curr Med Res Opin. 2008 Dec;24(12):3423-34. doi: 10.1185/03007990802550679 . Review.

PMID:
19032124
44.

High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough.

Kapaskelis AM, Vouloumanou EK, Rafailidis PI, Hatzopoulou P, Nikita D, Falagas ME.

Respir Med. 2008 Nov;102(11):1586-91. doi: 10.1016/j.rmed.2008.06.001. Epub 2008 Aug 6.

45.

Effectiveness and safety of short-course vs long-course antibiotic therapy for group a beta hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials.

Falagas ME, Vouloumanou EK, Matthaiou DK, Kapaskelis AM, Karageorgopoulos DE.

Mayo Clin Proc. 2008 Aug;83(8):880-9.

PMID:
18674472

Supplemental Content

Loading ...
Support Center